Genetic predisposition to higher production of interleukin-6 through -174 G > C polymorphism predicts global cognitive decline in oldest-old with cognitive impairment no dementia

Arq Neuropsiquiatr. 2015 Nov;73(11):899-902. doi: 10.1590/0004-282X20150137. Epub 2015 Oct 6.

Abstract

Interleukin 6 (IL-6) is a pro-inflammatory cytokine upregulated in neurodegenerative contexts. The polymorphism IL-6 -174 G > C influences release levels of this cytokine. We aimed to evaluate the influence of IL-6 -174 G > C on global cognitive score of a group with cognitive impairment no dementia in one year of follow-up.Methods The subjects were categorized in two groups: short-term decline in global cognitive score and those with short-term stability or improvement. IL-6 174 G > C information were compared among these groups.Results We observed that individuals with cognitive impairment no dementia with GGlowergenotype were more frequent among global cognitive score non-decliners while carriers of at least one Chigherallele were more frequent in the group with global cognitive score decliners (p = 0.012; RR = 3.095 IC95%= 1.087-8.812).Conclusion These results suggest that the higher expression of IL-6 gene may be an independent risk factor for cognitive decline among individuals with cognitive impairment no dementia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Cognition Disorders / genetics*
  • Cognition Disorders / metabolism
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease*
  • Genotyping Techniques
  • Humans
  • Interleukin-6 / biosynthesis*
  • Interleukin-6 / blood
  • Interleukin-6 / genetics*
  • Male
  • Neuropsychological Tests
  • Polymorphism, Single Nucleotide*
  • Prospective Studies
  • Risk Factors
  • Severity of Illness Index

Substances

  • Interleukin-6